This white paper discusses how Shields care model and patient management system help overcome common barriers to addressing SDOH by allowing for the use of data insights to screen patients…
This white paper discusses how health system-owned specialty pharmacies leveraging Shields’ integrated care model, data aggregation and acceleration solutions can overcome challenges and barriers to care for specialty patients with…
This white paper discusses how a specialty pharmacy acceleration company allows drug manufacturers to access the expertise of health systems and their specialty pharmacies through a single point of contact.…
This white paper describes the impact of health system specialty pharmacy utilizing an integrated care model on clinical outcomes and total cost of care.
This white paper explores the benefits of applying a high-touch specialty pharmacy care model, such as the Shields Diabetes Care Program, in reducing HbA1c levels and providing other clinical and…
This white paper explores how a high-touch integrated specialty pharmacy care model can help patients with cystic fibrosis manage the complexity of their treatment regimen and achieve their therapy goals.…
This white paper explores how a high-touch IDN (Integrated Delivery Network) specialty pharmacy model can help MS patients overcome barriers to medication access and achievement of therapy goals, including limited…
This white paper describes the growth of health system specialty pharmacy in recent years, acknowledges the disruption caused by COVID-19, and discusses opportunities to optimize specialty pharmacy with data-driven solutions,…
This white paper highlights the importance of collaboration between payers and health systems and the benefits of carving in specialty pharmacy access at the point of care. These partnerships are…
